Clinical Trial Update: OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)

View source ↗

Summary

The OASIS STUDY, sponsored by Kyorin Pharmaceutical Co., Ltd, completed a trial assessing health-related quality of life using SF-36 v2 in stroke patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Kyorin Pharmaceutical Co.,Ltd | Conditions: Stroke | Status: COMPLETED